Purpose

The investigators aim to characterize patients presenting with a severe ventricular tachycardia (VT) and premature ventricular complex (PVC)-ablation-related complication including patient characteristics, procedural details and subsequent management of the complication by gathering existing patient-level data.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Centers : Centers participating in the present collaborative study group. Invitation to participate will be based either upon personal referral of one of the investigator, previous collaboration or based on a meta-analytic review of the literature published on the subject within the past 20 years. - Patients: Females and males of >18 years undergoing any type of VT/PVC ablation. While we will accept redo-procedure we will ask for a unique patient-identifier to link procedures belonging to the same patients together. - Interventions: VT/PVC ablation (first intervention or re-do) as routinely performed by the participating centers - Outcomes: Severe complications, defined as hemodynamic instability requiring mechanical intensive-care management, tamponade, stroke, cardiac arrest, myocardial infarction, phrenic nerve palsies, major bleeding requiring transfusion, vascular or cardiac complication requiring surgery, procedure-related death. - Setting: Observational cohort studies, registries, retrospective cohort studies. Data stemming from RCTs (Randomized controlled trials) will not be collected as they likely do not represent a "real-life" setting. - Length of follow-up: Peri-procedural complications - Years considered: Not limited to a specific time-frame, but to reflect common ablation practices, we will focus on data from the 20 past years. - Number of patients provided : No lower limit of patients provided per dataset or ablation volume per year to include high- as well as low-volume centers

Exclusion Criteria

  • Refusal of the center to participate. - Less than 10 procedures available in the dataset (no case reports) - Missing essential baseline characteristics, missing collection of sufficient details regarding each complication.

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Recruiting Locations

Rush University Medical Center
Chicago, Illinois 60612
Contact:
Henry Huang
312-942-5000
henry.huang@bsd.uchicago.edu

University of Michigan
Michigan Center, Michigan 48109
Contact:
Jackson Liang
734-936-4000
liangjac@med.umich.edu

More Details

Status
Recruiting
Sponsor
University Hospital, Basel, Switzerland

Study Contact

Michael Kühne, Prof. Dr. med.
0041 61 265 52 14
Michael.kuehne@usb.ch

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.